HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

CK Fragrance Portfolio Blooms With Lighter Version Of Euphoria

This article was originally published in The Rose Sheet

  • News

Executive Summary

Calvin Klein Euphoria Blossom fragrance for women is designed as a "modern, fresh counterpart" to the original Euphoria Calvin Klein scent, according to Coty Prestige

You may also be interested in...



Coty’s Five-Year Growth Strategy Presented By CEO Beetz

Coty is aiming to nearly double its size within the next five years to become a $5 bil. company and a top five player in the global beauty market, CEO Bernd Beetz stated during an Oct. 6 press briefing

Coty’s Five-Year Growth Strategy Presented By CEO Beetz

Coty is aiming to nearly double its size within the next five years to become a $5 bil. company and a top five player in the global beauty market, CEO Bernd Beetz stated during an Oct. 6 press briefing

Calvin Klein Euphoric Over “Sexy, Provocative” New Fragrance

Euphoria Calvin Klein women's fragrance is positioned to bring "renewed energy and aspiration" to the brand, according to Unilever Cosmetics International

Table

View full table

Tags:
Latest Headlines

Probiotics And Cold Remedies Boost Recordati In 2023

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches

See All
UsernamePublicRestriction

Register

RS014260

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By